Oaktree Acquisition Corp. III Life Sciences Files 8-K
Ticker: OACCU · Form: 8-K · Filed: Jun 6, 2025 · CIK: 2029769
| Field | Detail |
|---|---|
| Company | Oaktree Acquisition Corp. III Life Sciences (OACCU) |
| Form Type | 8-K |
| Filed Date | Jun 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, leadership-change, filing
TL;DR
Oaktree Acquisition Corp. III Life Sciences filed an 8-K on June 3, 2025, detailing leadership changes and compensation.
AI Summary
Oaktree Acquisition Corp. III Life Sciences filed an 8-K on June 6, 2025, reporting changes related to director departures, elections, and officer appointments. The filing also covers compensatory arrangements for certain officers. The report date for the earliest event is June 3, 2025.
Why It Matters
This filing indicates potential shifts in the company's leadership and compensation structures, which could impact strategic direction and investor confidence.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of corporate governance and personnel changes, not indicating immediate financial distress or significant operational shifts.
Key Players & Entities
- Oaktree Acquisition Corp. III Life Sciences (company) — Registrant
- June 3, 2025 (date) — Earliest event reported
- June 6, 2025 (date) — Date of report
FAQ
What specific items are being reported in this 8-K filing?
This 8-K reports on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is Oaktree Acquisition Corp. III Life Sciences.
In which jurisdiction was Oaktree Acquisition Corp. III Life Sciences incorporated?
Oaktree Acquisition Corp. III Life Sciences was incorporated in the Cayman Islands.
What is the Commission File Number for Oaktree Acquisition Corp. III Life Sciences?
The Commission File Number for Oaktree Acquisition Corp. III Life Sciences is 001-42383.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is June 3, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 6, 2025 regarding Oaktree Acquisition Corp. III Life Sciences (OACCU).